The Adamed Group is a Polish pharmaceutical and biotechnology company that is a leader on the Polish market of next generation drugs
In 2010 the Adamed Group was formed and includes Adamed, Polfa Pabianice and Adamed Consumer Healthcare
Adamed`s core expertise is development, manufacturing and marketing of etical drugs. In the care of patients.
For over 25 years the company has been providing patients with medicinal products of the highest quality in many therapeutic groups.
Adamed develops new generics, which can guarantee the highest quality and safety of therapy.
Most of our products that are indicated in such therapeutic groups as cardiology, psychiatry, pulmonology, gynecology or urinary tract infections are therapy class leaders in Poland.
Adamed offers high quality dossiers and a supply capacity for bulk or finished formulations.
Adamed has an extensive pipeline of generic products under development. A number of most reputable players of the pharmaceuitacal markets in Europe, ME, CIS and China are our reference partners.
Adamed also invests in research that is set to find effective and innovative original drugs which can be used for the most common diseases of our times like diabetes or tumors.
- Core Sales Territory:
Global Regulated Markets
- Formed: 1986
- Number of employees: 670